MELAS SYNDROME
Clinical trials for MELAS SYNDROME explained in plain language.
Never miss a new study
Get alerted when new MELAS SYNDROME trials appear
Sign up with your email to follow new studies for MELAS SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a fat compound help fight rare energy disorders?
Disease control Recruiting nowThis study tests an oral drug called glycerol tributyrate in 24 adults with MELAS or LHON-Plus, two rare genetic diseases that affect energy production in cells. The goal is to see if the drug is safe and can improve energy metabolism. Each participant serves as their own control…
Matched conditions: MELAS SYNDROME
Phase: PHASE1, PHASE2 • Sponsor: George Washington University • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
New hope for rare mitochondrial disease: oral drug trial launches
Disease control Recruiting nowThis study tests an oral medication called TTI-0102 in 12 people with MELAS, a rare genetic disorder that causes muscle weakness, strokes, and fatigue. Participants receive either the drug or a placebo for 6 months to see if it improves walking distance, tiredness, and quality of…
Matched conditions: MELAS SYNDROME
Phase: PHASE2 • Sponsor: Thiogenesis Therapeutics, Inc. • Aim: Disease control
Last updated Apr 26, 2026 19:37 UTC